Wolters Kluwer Webinar Brings Together Nursing Leaders to Discuss New Technologies

Webinar will examine the influence of ChatGPT, generative AI and more on nursing education

Across industries, the influx of new technology is continuing to roll out at a break-neck pace, with artificial intelligence (AI) at the forefront. To examine the opportunities and risks in using new technologies for research, evidence based practice (EBP) and quality improvement (QI) Wolters Kluwer Health, will host an online event titled, “Achieving academic excellence in nursing with new technologies: An Ovid® Synthesis webinar,” on Tuesday, June 13th from 2 to 3pm ET.

“In the midst of rapid adoption of AI-based technologies globally, a range of concerns ranging from academic integrity to plagiarism to misinformation has heightened the awareness among educators surrounding a need for action,” said Vikram Savkar, Senior Vice President & General Manager, Medicine Segment, Health Learning, Research & Practice at Wolters Kluwer Health. “The academic landscape must examine the best ways to benefit from these technologies while understanding the risks that may come with the implementation.”

The issues facing faculty and nursing students when it comes to using new technologies can seem overwhelming, so it is especially important to understand how generative AI could be used in developing research, EBP, and QI projects. In addition to the conversation around AI, the expert group will highlight how Ovid Synthesis can support a learning environment that promotes independent critical thinking and academic integrity.

The distinguished group of panelists that will discuss the oversight, guidance and support needed for academia facing this inflection point, includes:

  • Marilyn H. Oermann, PhD, RN, ANEF, FAAN, Thelma M. Ingles Professor of Nursing, Duke University School of Nursing; Editor-in-Chief, Nurse Educator
  • Grace H. Sun, MSN, NP, Associate Professor, Texas Tech University Health Sciences Center
  • Stephanie H. Hoelscher, DNP, RN-BC, CPHIMS, CHISP, FHIMSS, Associate Professor of Graduate Informatics and an Informatics Nurse Specialist, Texas Tech University Health Sciences Center
  • Shea Polancich, PhD, RN, Associate Professor and Assistant Dean, University of Alabama at Birmingham School of Nursing
  • (Host) Rachel Dicker, Product Management Associate Director, Wolters Kluwer, Health Learning, Research & Practice

Working in tandem with other groundbreaking technologies, Ovid Synthesis serves as a research repository, allowing all project information to be organized and stored in one simple solution, eliminating breakdowns and stalled projects. Learn more about how Ovid Synthesis can support your organization’s academic research challenges.

Wolters Kluwer Health provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. The division of Wolters Kluwer supports clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”